Barkley, R.A.: A review of stimulant drug research with hyperactive children. Journal of Child Psychology and Psychiatry, 1977, 18, 137–165.
2.
Bensch, J., Blennow, G., Ferngren, H., Gamstorp, I.Herrlin, K.M., Kubista, J., Arvidsson, A., & Dahlstrom, H.: A double blind study of clonazepam in the treatment of therapy-resistant epilepsy in children. Developmental Medicine and Child Neurology, 1977, 19, 335–342.
3.
Berman, P.H.: Management of seizure disorders with anticonvulsant drugs: Current concepts. Pediatric Clinics of North America, 1976, 23(3), 443–459.
4.
Bleiycr, W.A.Surveillance of pediatric adverse drug reactions: A neglected health care programPediatrics, 1975, 15, 308–310.
5.
Buda, F.B., Joyce, R.P., & Zettett, P.G.: Use of high dosage phenobarbital in the treatment of neonatal status epiliplicus: A preliminary report. Military Medicine, 1979, 144, 456–459.
6.
Campbell, M., Fish, B., Shapiro, T., & Floyd, A. Jr.: Imipramine in preschool autistic and schizophrenic children. Journal of Autism and Childhood Schizophrenia, 1971, 1, 267–282.
7.
Campbell, M., Fish, B., Korein, J., Shapiro, T., Collins, P., & Koh, C.: Lithium and chlorpromazine: A controlled crossover study of hyperactive severely disturbed young children. Journal of Autism and Childhood Schizophrenia, 1972, 2, 234–263. (a)
8.
Campbell, M., Fish, B., David, R., Shapiro, T., Collins, P., & Koh, C.: Response to triiodothyronine and dextroamphetamine: a study of preschool schizophrenic children. Journal of Autism and Childhood Schizophrenia, 1972, 2, 343–358. (b)
9.
Campbell, M., Fish, B., David, R., Shapiro, T., Collins, P., & Koh, C.: Liothyronine treatment in psychotic and nonpsychotic children under 6 years. Archives of General Psychiatry, 1973, 29, 602–608.
10.
Campbell, M., Anderson, L.T., Meier, M., Cohen, I.L., Small, A.M., Samit, C., & Sacher, E.J.: A comparison of haloperidol and behavior therapy and their interaction in autistic children. Journal of the American Academy of Child Psychiatry, 1978, 17, 640–655.
11.
Campbell, M., & Small, A.M.Chemotherapy. In B.B. Wolman, J. Egan, & A.O. Russ (Eds.), Handbook of treatment of mental disorders in childhood and adolescenceEnglewood Cliffs, N.J.: Prentice-Hall, 1978.
12.
Campbell, M., Small, A.M., Hollander, C.S., Korein, J., Cohen, I.L., Kalmijn. M., & Ferris, S.: A contrclled crossover study of triiodothyronine in autistic children. Journal of Autism and Childhood Schizophrenia, 1978, 8, 371–381.
13.
Cohen, M.J. (Ed.). Drugs and the special child. New York: Gardner Press, 1979.
14.
Cohen, I.L., Campbell, M., Posner, D., Small, A.M., Triebel, D., & Anderson, L.T.: Behavioral effects of haloperidol in young autistic children: An objective analysis using a within subjects reversal design. Journal of the American Academy of Child Psychiatry, 1980, 19, 665–677.
Coulter, D.L., Wu, H., & Allen, R.J.: Valproic acid therapy in childhood epilepsy. Journal of the American Medical Association, 1980, 244(8), 785–788.
17.
Donaldson, J.Y., & Menolascino, F.J.Therapeutic and preventive intervention in mental retardation. In G.P. Sholeyar, R.M. Benson, & B.J. Blinder (Eds.), Emotional disorders in children and adolescentsNew York: Spectrum Publications, 1980.
18.
Engelhardt, D.M., Polizos, P., Waizer, J., & Hoffman, S.P.: A double-blind comparison of fluphenazine and haloperidol in outpatient schizophrenic children. Journal of Autism and Childhood Schizophrenia, 1973, 3, 128–137.
19.
Faretra, G., Dooher, L., & Dowling, J.: Comparison of haloperidol and fluphenazine in disturbed children. American Journal of Psychiatry, 1970, 126, 1670–1673.
20.
FDA Drug Bulletin, 1980, 10(3). Rockville, Md.: Dept. of Health and Human Services.
21.
Gadow, K.D.Children on medication: A primer for school personnel. Reston, Va.: Council for Exceptional Children, 1979.
22.
Gittelman-Klein, R.: Psychopharmacology in children. Drug Therapy, 1978, 8, 137–147.
23.
Golden, G.S.: Nonstandard therapies in the developmental disabilities. American Journal of Diseases of Children, 1980, 134, 487–491.
24.
Greer, J.G., Davis, T.B., & Yearwood, K.: Drug treatment: Factors contributing to high risk in institutions. Exceptional Children, 1977, 43(7), 451–453.
25.
Gross, F., Boreus, L.O., Deutsch, E., Gladtke, E., Helge, H., Mirkin, B.L., Morselli, P.L., Sereni, F., & Yaffe, S.J.: Medical, ethical and legal aspects of clinical trials in pediatrics. European Journal of Clinical Pharmacology, 1980, 18, 121–127.
26.
Gualtieri, C. T.: Imipramine and children. A review and some speculations about the mechanism of drug action. Disorders of the Nervous System, 1977, 38, 368–375.
27.
Haggerty, R.J., & Roghmann, K.J.: Non-compliance and self-medication—Two neglected aspects of pediatric pharmacology. Pediatric Clinics of North America, 1972, 19, 101–115.
28.
Harte, V.J., & Timoney, R.F.Drug prescribing in paediatric medicine. Journal of the Irish Medical Association, 1980, 73, 157.
29.
Herha, J., & Obe, G.Chromosomal damage in epileptics on monotherapy with carbamazepine and diphenylhydantoin. Human Genetics. 1976, 34, 255–263.
30.
Iivanainen, M., Viukari, M., & Helle, E.P.: Cerebellar atrophy in phenytoin treated mentally retarded epileptics. Epilepsia, 1977, 18, 375–386.
31.
Knudsen, B.: Rectal administration of diazepam in soluticn in the acute treatment of convulsions in infants and children. Archives of Disease in Childhood, 1979, 54, 855–857.
32.
Leary, P.M., & Morris, S.Clinical experience with sodium valproate in children. South American Medical Journal, 1980, 866–867.
33.
Lindsey, C.N., Leibold, S.R., Ladd, F.T., & Ownby, R. Jr.: Children on medication: A guide for teachers. Rehabilitation Literature, 1980, 41, 124–126.
34.
May, E.: Drugs in use in school for severely subnormal children. Child: Care, Health and Development, 1976, 2, 261–266.
35.
Meissner, H.C., & Smith, A.L.: The current status of chloramphenicol. Pediatrics, 1979, 64, 348–356.
36.
Meistrup-Larsen, K.I., Hermann, S., & Permin, H.: Chronic diphenylhydantoin encephalopathy in mentally retarded children and adolescents with severe epilepsy. Acta Neurologica Scandinavica, 1979, 60, 50–55.
37.
Moreland, T.A., Rylance, G.W., Christopher, L.J., & Stevenson, I.H.: Patterns of drug prescribing for children in hospital. European Journal of Clinical Pharmacology, 1978, 14, 39–46.
38.
Neisworth, J.T., Kurtz, P.D., Ross, A., & Madle, R.A.: Naturalistic assessment of neurological diagnoses and pharmacological intervention. Journal of Learning Disabilities, 1976, 9(3), 22–25.
39.
Rylance, G.: Prescribing in infancy and childhood. British Journal of Hospital Medicine, 1979, 22, 346–354.
40.
Schleifer, M., Weiss, G., Cohen, N., Elman, M., Cvejic, H., & Kruger, E.: Hyperactivity in preschoolers and the effect of methylphenidate. American Journal of Orthopsychiatry, 1975, 45, 38–50.
41.
Silver, L.B.Drug therapy with children and adolescents. In M.J. Cohen (Ed.), Drugs and the special childNew York: Gardner Press, 1979.
42.
Simeonsson, R.J.Carolina Record of Infant Behavior. Unpublished manuscript, University of North Carolina at Chapel Hill, 1979.
43.
Simeonsson, R.J., Huntington, G.S., & Parse, S.A.: Expanding the developmental assessment of young handicapped children. New Directions for Exceptional Children, 1980, 3, 51–74.
44.
Sprague, R., & Sleator, E.Drugs and dosages: Implications for learning disabilities. In R.M. Knights & D. Bakker (Eds.), The neuropsychology of learning disordersBaltimore: University Park Press, 1976.
45.
Stores, G.: Behavioural effects of anti-epileptic drugs. Developmental Medicine and Child Neurology, 1975, 17, 647–657.
46.
Sroufe, L.A.Drug treatment of children with behavior problems. In Horwitz et al. (Eds.), Review of child development research, Vol. 4 Chicago: University of Chicago Press, 1975.
47.
Vallarta, J.M., Beil, D.B., & Reichert, A.Progressive encephalopathy due to chronic hydantoin intoxication. American Journal of Diseases of Children, 1974, 128, 27–34.
48.
Windorfer, A., & Sauer, W.: Drug interactions during anticonvulsant therapy in childhood: Diphenylhydantoin, primidone, phenobarbitone, clonazepam, nitrazepam, carbamazepin and dipropylacetate. Neuropadiatrie, 1977, 8, 29–41.
49.
Winnacker, J.L., Yeager, H., Saunders, J.A., Russell, B., & Anast, C.S.Rickets in children receiving anticonvulsant drugs. American Journal of Diseases of Children, 1977, 131, 286.
50.
Wolf, S.M.The effectiveness of phenobarbital in the prevention of recurrent febrile convulsions in children with and without a history of pre. and postnatal abnormalities. Acta Paediatrica Scandinavica1977, 66, 585–587.
51.
Yaffe, S.J.: Clinical implications of perinatal pharmacology. European Journal of Clinical Pharmacology, 1980, 18, 3–7.
52.
Zinsmeister, S., & Marks, R.E.: Acute athetosis as a result of phenytoin toxicity in a child. American Journal of Diseases of Children, 1976, 130, 75–76.